Can Esophagectomy be Safely Avoided After Clinical Complete Response in Esophageal Squamous Cell Carcinoma? Response Assessment, Active Surveillance, and Salvage in the Immunotherapy Era

Tamotsu Sagawa, Masahiro Hirakawa, Hiroyuki Nagashima, Koshi Fujikawa

Open source

DOI
10.1007/s11912-026-01857-5
Published
2026-11-03
Container
Current Oncology Reports
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s11912-026-01857-5,
  title = {Can Esophagectomy be Safely Avoided After Clinical Complete Response in Esophageal Squamous Cell Carcinoma? Response Assessment, Active Surveillance, and Salvage in the Immunotherapy Era},
  author = {Tamotsu Sagawa and Masahiro Hirakawa and Hiroyuki Nagashima and Koshi Fujikawa},
  year = {2026},
  journal = {Current Oncology Reports},
  doi = {10.1007/s11912-026-01857-5},
  url = {https://doi.org/10.1007/s11912-026-01857-5}
}

RIS

TY  - JOUR
TI  - Can Esophagectomy be Safely Avoided After Clinical Complete Response in Esophageal Squamous Cell Carcinoma? Response Assessment, Active Surveillance, and Salvage in the Immunotherapy Era
AU  - Tamotsu Sagawa
AU  - Masahiro Hirakawa
AU  - Hiroyuki Nagashima
AU  - Koshi Fujikawa
PY  - 2026
JO  - Current Oncology Reports
DO  - 10.1007/s11912-026-01857-5
UR  - https://doi.org/10.1007/s11912-026-01857-5
ER  - 

APA

Sagawa, T., Hirakawa, M., Nagashima, H., & Fujikawa, K. (2026). Can Esophagectomy be Safely Avoided After Clinical Complete Response in Esophageal Squamous Cell Carcinoma? Response Assessment, Active Surveillance, and Salvage in the Immunotherapy Era. Current Oncology Reports. https://doi.org/10.1007/s11912-026-01857-5

Source records